PNS and CNS drugs Flashcards
Drug class and indications of
Escitalopram
SSRI
Major Depression
General Anxiety Disorder
SSRI P450 inhibitors
Drug interactions
Dosing instructions
Fluvoxamine
Fluoxetine
Paroxetine
Drug interactions: TCAs and Lithium
Decrease dose in patients with liver problems
SSRI with active metabolite
Fluoxetine
Drug interactions of SSRIs
- Tramadol = increased seizure risk
- NSAIDS = decrease SSRI function
- Warfarin = displaced from plasma proteins
- MAOIs = Serotonin syndrome
- TCAs and Lithium with Paroxetine/Fluvoxamine/Fluoxetine = inhibit P450, increasing levels of TCAs and Lithium
SSRI and Tramadol
Seizure
SSRI and NSAIDs
Decreased SSRI action
SSRI and warfarin
Decreased W binding to plasma cells and increased action
SSRIs are highly Protein binding!!
SSRIs and MAOIs
Time to wait before switching drug type
Serotonin Syndrome
Start SSRIs 14 days post-MOAIs
Start MAOIs 7 days post-SSRIs
Paroxetine/Fluvoxamine/Fluoxetine and Lithium or TCAs
Inhibit P450, decreasing metabolism and increasing action
SSRI with risk of Torsadede pointes
Citalopram
Increased QT interval
Ventricular tachycardia
Fluoxamine and Sumatriptan
Fluoxmine is SSRI
weakness, hyperreflexia, incoordination
Side effects of Fluoxetine
Sexual dysfunction
Weight gain (different from other SSRIs)
Bleeding disorders
extrapyramidal signs
SNRI with active metabolite
Venlafaxine
SNRI that inhibits P450
Duloxetine
Duloxetine and Thioridazine
Increased risk of ventricular dysrhythmias (Duloxetine has greater effect on NE than venlafaxine)